PALIVIZUMAB, DEVELOPMENT OF THE FIRST BIOSIMILAR FOR THE TREATMENT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (SRV) (Q3180310)

From EU Knowledge Graph
Jump to navigation Jump to search
Project Q3180310 in Spain
Language Label Description Also known as
English
PALIVIZUMAB, DEVELOPMENT OF THE FIRST BIOSIMILAR FOR THE TREATMENT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (SRV)
Project Q3180310 in Spain

    Statements

    country
    Spain
    0 references
    EU contribution
    1,018,304.3 Euro
    0 references
    budget
    1,870,164.0 Euro
    0 references
    co-financing rate
    54.45 percent
    0 references
    start time
    23 September 2015
    0 references
    end time
    31 December 2017
    0 references
    beneficiary name (string)
    GH GENHELIX SOCIEDAD ANONIMA
    0 references
    beneficiary
    Q3163419
    0 references
    coordinate location

    42°35'39.59"N, 5°35'16.94"W
    inferred from
    postal code
    0 references
    postal code
    24009
    0 references
    summary
    PALIVIZUMAB, DESARROLLO DEL PRIMER BIOSIMILAR PARA EL TRATAMIENTO DEL VIRUS SINCITIAL RESPIRATORIO (VSR) HUMANO (Spanish)
    0 references
    PALIVIZUMAB, DEVELOPMENT OF THE FIRST BIOSIMILAR FOR THE TREATMENT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (SRV) (English)
    point in time
    12 October 2021
    readability score
    0.0066898901419791
    0 references
    PALIVIZUMAB, DÉVELOPPEMENT DU PREMIER BIOSIMILAIRE POUR LE TRAITEMENT DU VIRUS RESPIRATOIRE SYNCYTIAL HUMAIN (SRV) (French)
    point in time
    4 December 2021
    0 references
    PALIVIZUMAB, ENTWICKLUNG DES ERSTEN BIOSIMILARS FÜR DIE BEHANDLUNG VON HUMANEM ATEMSYCYTIALVIRUS (SRV) (German)
    point in time
    9 December 2021
    0 references
    PALIVIZUMAB, ONTWIKKELING VAN DE EERSTE BIOSIMILAR VOOR DE BEHANDELING VAN HUMAN RESPIRATORY SYNCYTIAL VIRUS (SRV) (Dutch)
    point in time
    17 December 2021
    0 references
    PALIVIZUMAB, SVILUPPO DEL PRIMO BIOSIMILARE PER IL TRATTAMENTO DEL VIRUS SINIZIALE RESPIRATORIO UMANO (SRV) (Italian)
    point in time
    16 January 2022
    0 references
    PALIVIZUMAB, ΑΝΆΠΤΥΞΗ ΤΟΥ ΠΡΏΤΟΥ ΒΙΟΟΜΟΕΙΔΟΎΣ ΓΙΑ ΤΗ ΘΕΡΑΠΕΊΑ ΤΟΥ ΑΝΘΡΏΠΙΝΟΥ ΑΝΑΠΝΕΥΣΤΙΚΟΎ ΣΥΝΚΥΤΤΑΡΙΚΟΎ ΙΟΎ (SRV) (Greek)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, UDVIKLING AF DET FØRSTE BIOSIMILÆRE LÆGEMIDDEL TIL BEHANDLING AF HUMAN RESPIRATORISK SYNCYTIALVIRUS (SRV) (Danish)
    point in time
    18 August 2022
    0 references
    PALIVITSUMABI, ENSIMMÄISEN BIOSIMILAARIN KEHITTYMINEN IHMISEN HENGITYSTEIDEN SYNSYTIAALISEN VIRUKSEN (SRV) HOITOON (Finnish)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, ŻVILUPP TAL-EWWEL BIJOSIMILI GĦALL-KURA TAL-VIRUS SINTIJALI RESPIRATORJU UMAN (SRV) (Maltese)
    point in time
    18 August 2022
    0 references
    PALIVIZUMABS, PIRMĀ BIOLĪDZĪGA CILVĒKA RESPIRATORĀ SINCITIĀLĀ VĪRUSA (SRV) ĀRSTĒŠANAI (Latvian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, VÝVOJ PRVÉHO BIOLOGICKY PODOBNÉHO NA LIEČBU ĽUDSKÉHO RESPIRAČNÉHO SYNCYCIÁLNEHO VÍRUSU (SRV) (Slovak)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, FORBAIRT AN CHÉAD BHITHSHAMHLACHA CHUN CÓIREÁIL A DHÉANAMH AR VÍREAS SYNCYTIAL RIOSPRÁIDE DAONNA (SRV) (Irish)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, VÝVOJ PRVNÍHO BIOLOGICKY PODOBNÉHO PRO LÉČBU LIDSKÉHO RESPIRAČNÍHO SYNCYTIÁLNÍHO VIRU (SRV) (Czech)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, DESENVOLVIMENTO DO PRIMEIRO BIOSSIMILAR PARA O TRATAMENTO DO VÍRUS SINCICIAL RESPIRATÓRIO HUMANO (SRV) (Portuguese)
    point in time
    18 August 2022
    0 references
    PALIVISUMAB, ESIMESE SARNASE BIOLOOGILISE RAVIMI VÄLJATÖÖTAMINE INIMESE RESPIRATOORSE SÜNTSÜTIAALSE VIIRUSE (SRV) RAVIKS (Estonian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, A HUMÁN LÉGZŐSZERVI SYNCYTIAL VIRUS (SRV) KEZELÉSÉRE SZOLGÁLÓ ELSŐ BIOHASONLÓ KIALAKULÁSA (Hungarian)
    point in time
    18 August 2022
    0 references
    ПАЛИВИЗУМАБ, РАЗРАБОТВАНЕ НА ПЪРВИЯ БИОПОДОБЕН ПРОДУКТ ЗА ЛЕЧЕНИЕ НА ЧОВЕШКИ РЕСПИРАТОРЕН СИНЦИТИАЛЕН ВИРУС (SRV) (Bulgarian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMABAS, PIRMOJO BIOLOGIŠKAI PANAŠAUS ŽMOGAUS KVĖPAVIMO SINCITINIO VIRUSO (SRV) GYDYMAS (Lithuanian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, RAZVOJ PRVOG BIOSLIČNOG LIJEKA ZA LIJEČENJE HUMANOG RESPIRATORNOG SINCICIJSKOG VIRUSA (SRV) (Croatian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, UTVECKLING AV DEN FÖRSTA BIOSIMILAREN FÖR BEHANDLING AV HUMANT RESPIRATORISKT SYNCYTIALVIRUS (SRV) (Swedish)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, DEZVOLTAREA PRIMULUI BIOSIMILAR PENTRU TRATAMENTUL VIRUSULUI SINCIȚIAL RESPIRATOR UMAN (VSR) (Romanian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, RAZVOJ PRVEGA PODOBNEGA BIOLOŠKEGA ZDRAVILA ZA ZDRAVLJENJE HUMANEGA RESPIRATORNEGA SINCICIJSKEGA VIRUSA (SRV) (Slovenian)
    point in time
    18 August 2022
    0 references
    PALIVIZUMAB, ROZWÓJ PIERWSZEGO LEKU BIOPODOBNEGO W LECZENIU LUDZKIEGO SYNCYTIALNEGO WIRUSA ODDECHOWEGO (SRV) (Polish)
    point in time
    18 August 2022
    0 references
    location (string)
    León
    0 references
    date of last update
    20 December 2023
    0 references

    Identifiers

    Spanish Kohesio ID
    IDI-20151113
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3180310&oldid=40209918"